Sleep disorders in Parkinson's disease

Handbook of Clinical Neurology

Volumn 99, Issue C, 2011, Pages 997-1010

  Videnovic, Aleksandar ^a   Comella, Cynthia L ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOOK; HUMAN; PARKINSON DISEASE; SLEEP DISORDER;

HUMANS; PARKINSON DISEASE; SLEEP DISORDERS;

EID: 78149382349     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52007-4.00019-9     Document Type: Book

References (195)

1. Abbott R.D., Ross G.W., White L.R., et al. Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology 2005, 65:1442-1446.
2. Abe K., Hikita T., Sakoda S. Sleep disturbances in Japanese patients with Parkinson's disease - comparing with patients in the UK. J Neurol Sci 2005, 234:73-78.
3. Adler C.H., Caviness J.N., Hentz J.G., et al. Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease. Mov Disord 2003, 18:287-293.
4. Albin R.L., Koeppe R.A., Chervin R.D., et al. Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology 2000, 55:1410-1412.
5. Allen R.P., Earley C.J. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 1996, 19:205-213.
6. Apps M.C., Sheaff P.C., Ingram D.A., et al. Respiration and sleep in Parkinson's disease. J Neurol Neurosurg Psychiatry 1985, 48:1240-1245.
7. April R.S. Observations on parkinsonian tremor in all-night sleep. Neurology 1966, 16:720-724.
8. Arnulf I. Excessive daytime sleepiness in parkinsonism. Sleep Med Rev 2005, 9:185-200.
9. Arnulf I., Bonnet A.M., Damier P., et al. Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis. Neurology 2000, 55:281-288.
10. Arnulf I., Konofal E., Merino-Andreu M., et al. Parkinson's disease and sleepiness: an integral part of PD. Neurology 2002, 58:1019-1024.
11. Arnulf I., Merino-Andreu M., Bloch F., et al. REM sleep behavior disorder and REM sleep without atonia in patients with progressive supranuclear palsy. Sleep 2005, 28:349-354.
12. Askenasy J.J. Sleep in Parkinson's disease. Acta Neurol Scand 1993, 87:167-170.
13. Askenasy J.J., Yahr M.D. Reversal of sleep disturbance in Parkinson's disease by antiparkinsonian therapy: a preliminary study. Neurology 1985, 35:527-532.
14. Askenasy J.J., Yahr M.D. Parkinsonian tremor loses its alternating aspect during non-REM sleep and is inhibited by REM sleep. J Neurol Neurosurg Psychiatry 1990, 53:749-753.
15. Barbar S.I., Enright P.L., Boyle P., et al. Sleep disturbances and their correlates in elderly Japanese American men residing in Hawaii. J Gerontol A Biol Sci Med Sci 2000, 55:M406-M411.
16. Bares M., Kanovsky P., Rektor I. Excessive daytime sleepiness and 'sleep attacks' induced by entacapone. Fundam Clin Pharmacol 2003, 17:113-116.
17. Baumann C., Ferini-Strambi L., Waldvogel D., et al. Parkinsonism with excessive daytime sleepiness - a narcolepsy-like disorder?. J Neurol 2005, 252:139-145.
18. Bergonzi P., Chiurulla C., Gambi D., et al. L-dopa plus dopa-decarboxylase inhibitor. Sleep organization in Parkinson's syndrome before and after treatment. Acta Neurol Belg 1975, 75:5-10.
19. Boeve B.F., Saper C.B. REM sleep behavior disorder: a possible early marker for synucleinopathies. Neurology 2006, 66:796-797.
20. Boeve B.F., Silber M.H., Ferman T.J., et al. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 2001, 16:622-630.
21. Boeve B.F., Silber M.H., Ferman T.J. Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med 2003, 4:281-284.
22. Boeve B.F., Silber M.H., Parisi J.E., et al. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology 2003, 61:40-45.
23. Boeve B.F., Silber M.H., Ferman T.J. REM sleep behavior disorder in Parkinson's disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol 2004, 17:146-157.
24. Boeve B.F., Lin S.C., Strongosky A., et al. Absence of rapid eye movement sleep behavior disorder in 11 members of the pallidopontonigral degeneration kindred. Arch Neurol 2006, 63:268-272.
25. Braak H., Del Tredici K., Rub U., et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003, 24:197-211.
26. Braak H., Rub U., Gai W.P., et al. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 2003, 110:517-536.
27. Braga-Neto P., Pereira da Silva-Junior F., et al. Snoring and excessive daytime sleepiness in Parkinson's disease. J Neurol Sci 2004, 217:41-45.
28. Brodsky M.A., Godbold J., Roth T., et al. Sleepiness in Parkinson's disease: a controlled study. Mov Disord 2003, 18:668-672.
29. Brotini S., Gigli G.L. Epidemiology and clinical features of sleep disorders in extrapyramidal disease. Sleep Med 2004, 5:169-179.
30. Brunner H., Wetter T.C., Hogl B., et al. Microstructure of the non-rapid eye movement sleep electroencephalogram in patients with newly diagnosed Parkinson's disease: effects of dopaminergic treatment. Mov Disord 2002, 17:928-933.
31. Cardoso S.M., Moreira P.I., Agostinho P., et al. Neurodegenerative pathways in Parkinson's disease: therapeutic strategies. Curr Drug Targets CNS Neurol Disord 2005, 4:405-419.
32. Chaudhuri K.R., Martinez-Martin P. Clinical assessment of nocturnal disability in Parkinson's disease: the Parkinson's Disease Sleep Scale. Neurology 2004, 63:S17-S20.
33. Chaudhuri K.R., Pal S., Brefel-Courbon C. 'Sleep attacks' or 'unintended sleep episodes' occur with dopamine agonists: is this a class effect?. Drug Saf 2002, 25:473-483.
34. Chaudhuri K.R., Pal S., DiMarco A., et al. The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002, 73:629-635.
35. Chakravorty S.S., Rye D.B. Narcolepsy in the older adult: epidemiology, diagnosis and management. Drugs Aging 2003, 20:361-376.
36. Coleman R.M., Bliwise D.L., Sajben N., et al. Daytime sleepiness in patients with periodic movements in sleep. Sleep 1982, 5(Suppl 2):S191-S202.
37. Comella C.L. Sleep disturbances in Parkinson's disease. Curr Neurol Neurosci Rep 2003, 3:173-180.
38. Comella C.L., Tanner C.M., Ristanovic R.K. Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations. Ann Neurol 1993, 34:710-714.
39. Comella C.L., Nardine T.M., Diederich N.J., et al. Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease. Neurology 1998, 51:526-529.
40. Comella C.L., Morrissey M., Janko K. Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy. Neurology 2005, 64:1450-1451.
41. Connor J.R., Boyer P.J., Menzies S.L., et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 2003, 61:304-309.
42. de Maindreville A.D., Fenelon G., Mahieux F. Hallucinations in Parkinson's disease: a follow-up study. Mov Disord 2005, 20:212-217.
43. Dhawan V., Dhoat S., Williams A.J., et al. The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography. J Neurol Sci 2006, 248:158-162.
44. Diederich N.J., Vaillant M., Leischen M., et al. Sleep apnea syndrome in Parkinson's disease. A case-control study in 49 patients. Mov Disord 2005, 20:1413-1418.
45. Diederich N.J., Vaillant M., Mancuso G., et al. Progressive sleep 'destructuring' in Parkinson's disease. A polysomnographic study in 46 patients. Sleep Med 2005, 6:313-318.
46. Drouot X., Moutereau S., Nguyen J.P., et al. Low levels of ventricular CSF orexin/hypocretin in advanced PD. Neurology 2003, 61:540-543.
47. Efthimiou J., Ellis S.J., Hardie R.J., et al. Sleep apnea in idiopathic and postencephalitic parkinsonism. Adv Neurol 1987, 45:275-276.
48. Eisensehr I., Linke R., Noachtar S., et al. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls. Brain 2000, 123(Part 6):1155-1160.
49. Eisensehr I., v Lindeiner H., Jager M., et al. REM sleep behavior disorder in sleep-disordered patients with versus without Parkinson's disease: is there a need for polysomnography?. J Neurol Sci 2001, 186:7-11.
50. Eisensehr I., Linke R., Tatsch K., et al. Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls. Sleep 2003, 26:507-512.
51. Fabbrini G., Barbanti P., Aurilia C., et al. Excessive daytime sleepiness in de novo and treated Parkinson's disease. Mov Disord 2002, 17:1026-1030.
52. Fabbrini G., Barbanti P., Aurilia C., et al. Excessive daytime somnolence in Parkinson's disease. Follow-up after 1 year of treatment. Neurol Sci 2003, 24:178-179.
53. Factor S.A., McAlarney T., Sanchez-Ramos J.R., et al. Sleep disorders and sleep effect in Parkinson's disease. Mov Disord 1990, 5:280-285.
54. Fantini M.L., Gagnon J.F., Filipini D., et al. The effects of pramipexole in REM sleep behavior disorder. Neurology 2003, 61:1418-1420.
55. Fenelon G., Mahieux F., Huon R., et al. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain 2000, 123(Part 4):733-745.
56. Ferini-Strambi L., Franceschi M., Pinto P., et al. Respiration and heart rate variability during sleep in untreated Parkinson patients. Gerontology 1992, 38:92-98.
57. Fitzpatrick A.J. Upper airway obstruction in Parkinson's disease. Anaesth Intensive Care 1995, 23:367-369.
58. Frauscher B., Hogl B., Maret S., et al. Association of daytime sleepiness with COMT polymorphism in patients with parkinson disease: a pilot study. Sleep 2004, 27:733-736.
59. Friedman J.H., Fernandez H.H., Sudarsky L.R. REM behavior disorder and excessive daytime somnolence in Machado-Joseph disease (SCA-3). Mov Disord 2003, 18:1520-1522.
60. Fronczek R., Overeem S., Lee S.Y., et al. Hypocretin (orexin) loss in Parkinson's disease. Brain 2007, 130(Part 6):1577-1585.
61. Frucht S.J., Greene P.E., Fahn S. Sleep episodes in Parkinson's disease: a wake-up call. Mov Disord 2000, 15:601-603.
62. Frucht S., Rogers J.D., Greene P.E., et al. Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 1999, 52:1908-1910.
63. Furumoto H. Excessive daytime somnolence in Japanese patients with Parkinson's disease. Eur J Neurol 2004, 11:535-540.
64. Gagnon J.F., Bedard M.A., Fantini M.L., et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease. Neurology 2002, 59:585-589.
65. Gagnon J.F., Fantini M.L., Bedard M.A., et al. Association between waking EEG slowing and REM sleep behavior disorder in PD without dementia. Neurology 2004, 62:401-406.
66. Gagnon J.F., Postuma R.B., Mazza S., et al. Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases. Lancet Neurol 2006, 5:424-432.
67. Garcia-Borreguero D., Schwarz C., Larrosa O., et al. L-DOPA-induced excessive daytime sleepiness in PD: a placebo-controlled case with MSLT assessment. Neurology 2003, 61:1008-1010.
68. Gjerstad M.D., Aarsland D., Larsen J.P. Development of daytime somnolence over time in Parkinson's disease. Neurology 2002, 58:1544-1546.
69. Gjerstad M.D., Wentzel-Larsen T., Aarsland D., et al. Insomnia in Parkinson's disease: frequency and progression over time. J Neurol Neurosurg Psychiatry 2007, 78:476-479.
70. Goetz C.G., Wilson R.S., Tanner C.M., et al. Relationships among pain, depression, and sleep alterations in Parkinson's disease. Adv Neurol 1987, 45:345-347.
71. Goetz C.G., Wuu J., Curgian L.M., et al. Hallucinations and sleep disorders in PD: six-year prospective longitudinal study. Neurology 2005, 64:81-86.
72. Graham J.M., Paley M.N., Grunewald R.A., et al. Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. Brain 2000, 123:2423-2431.
73. Grandas F., Iranzo A. Nocturnal problems occurring in Parkinson's disease. Neurology 2004, 63:S8-S11.
74. Guilleminault C., Cetel M., Philip P. Dopaminergic treatment of restless legs and rebound phenomenon. Neurology 1993, 43:445.
75. Happe S., Berger K. The association of dopamine agonists with daytime sleepiness, sleep problems and quality of life in patients with Parkinson's disease - a prospective study. J Neurol 2001, 248:1062-1067.
76. Herer B., Arnulf I., Housset B. Effects of levodopa on pulmonary function in Parkinson's disease. Chest 2001, 119:387-393.
77. 18F]fluorodopa uptake in the upper brainstem measured with positron emission tomography correlates with decreased REM sleep duration in early Parkinson's disease. Clin Neurol Neurosurg 2003, 105:262-269.
78. Hirsch E.C., Graybiel A.M., Duyckaerts C., et al. Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. Proc Natl Acad Sci U S A 1987, 84:5976-5980.
79. Hishikawa N., Hashizume Y., Yoshida M., et al. Clinical and neuropathological correlates of Lewy body disease. Acta Neuropathol (Berl) 2003, 105:341-350.
80. Hobson D.E., Lang A.E., Martin W.R., et al. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA 2002, 287:455-463.
81. Hogl B., Saletu M., Brandauer E., et al. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial. Sleep 2002, 25:905-909.
82. Hogl B., Rothdach A., Wetter T.C., et al. The effect of cabergoline on sleep, periodic leg movements in sleep, and early morning motor function in patients with Parkinson's disease. Neuropsychopharmacology 2003, 28:1866-1870.
83. Hogl B., Seppi K., Brandauer E., et al. Increased daytime sleepiness in Parkinson's disease: a questionnaire survey. Mov Disord 2003, 18:319-323.
84. Holloway R.G., Shoulson I., Fahn S., et al. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Arch Neurol 2004, 61:1044-1053.
85. Hovestadt A., Bogaard J.M., Meerwaldt J.D., et al. Pulmonary function in Parkinson's disease. J Neurol Neurosurg Psychiatry 1989, 52:329-333.
86. Iranzo A., Santamaria J., Rye D.B., et al. Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD. Neurology 2005, 65:247-252.
87. Jansen E.N., Meerwaldtt J.D. Madopar HBS in nocturnal symptoms of Parkinson's disease. Adv Neurol 1990, 53:527-531.
88. Jellinger K.A. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution-a pilot study. Acta Neuropathol (Berl) 2003, 106:191-201.
89. Johns M.W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991, 14:540-545.
90. Johns M.W. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 1992, 15:376-381.
91. Juncos J.L., Fabbrini G., Mouradian M.M., et al. Controlled release levodopa-carbidopa (CR-5) in the management of parkinsonian motor fluctuations. Arch Neurol 1987, 44:1010-1012.
92. Kales A., Ansel R.D., Markham C.H., et al. Sleep in patients with Parkinson's disease and normal subjects prior to and following levodopa administration. Clin Pharmacol Ther 1971, 12:397-406.
93. Kaynak D., Kiziltan G., Kaynak H., et al. Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment. Eur J Neurol 2005, 12:199-207.
94. Korner Y., Meindorfner C., Moller J.C., et al. Predictors of sudden onset of sleep in Parkinson's disease. Mov Disord 2004, 19:1298-1305.
95. Krishnan P.R., Bhatia M., Behari M. Restless legs syndrome in Parkinson's disease: a case-controlled study. Mov Disord 2003, 18:181-185.
96. Kumar S., Bhatia M., Behari M. Sleep disorders in Parkinson's disease. Mov Disord 2002, 17:775-781.
97. Kumar S., Bhatia M., Behari M. Excessive daytime sleepiness in Parkinson's disease as assessed by Epworth Sleepiness Scale (ESS). Sleep Med 2003, 4:339-342.
98. Kuno S., Mizuta E., Yamasaki S., et al. Effects of pergolide on nocturia in Parkinson's disease: three female cases selected from over 400 patients. Parkinsonism Relat Disord 2004, 10:181-187.
99. Kunz D., Bes F. Melatonin effects in a patient with severe REM sleep behavior disorder: case report and theoretical considerations. Neuropsychobiology 1997, 36:211-214.
100. Kunz D., Bes F. Melatonin as a therapy in REM sleep behavior disorder patients: an open-labeled pilot study on the possible influence of melatonin on REM-sleep regulation. Mov Disord 1999, 14:507-511.
101. Langston J.W. The Parkinson's complex: parkinsonism is just the tip of the iceberg. Ann Neurol 2006, 59:591-596.
102. Lavie P., Bental E., Goshen H., et al. REM ocular activity in Parkinsonian patients chronically treated with levodopa. J Neural Transm 1980, 47:61-67.
103. Lees A.J. A sustained-release formulation of L-dopa (Madopar HBS) in the treatment of nocturnal and early-morning disabilities in Parkinson's disease. Eur Neurol 1987, 27(Suppl 1):126-134.
104. Lees A.J., Blackburn N.A., Campbell V.L. The nighttime problems of Parkinson's disease. Clin Neuropharmacol 1988, 11:512-519.
105. Lesser R.P., Fahn S., Snider S.R., et al. Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy. Neurology 1979, 29:1253-1260.
106. Linazasoro G., Marti Masso J.F., Suarez J.A. Nocturnal akathisia in Parkinson's disease: treatment with clozapine. Mov Disord 1993, 8:171-174.
107. Manni R., Mazzarello P. Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis. Neurology 2001, 57:1350-1351.
108. Manni R., Pacchetti C., Terzaghi M., et al. Hallucinations and sleep-wake cycle in PD: a 24-hour continuous polysomnographic study. Neurology 2002, 59:1979-1981.
109. Maria B., Sophia S., Michalis M., et al. Sleep breathing disorders in patients with idiopathic Parkinson's disease. Respir Med 2003, 97:1151-1157.
110. Marinus J., Visser M., van Hilten J.J., et al. Assessment of sleep and sleepiness in Parkinson disease. Sleep 2003, 26:1049-1054.
111. Moller J.C., Rethfeldt M., Korner Y., et al. Daytime sleep latency in medication-matched Parkinsonian patients with and without sudden onset of sleep. Mov Disord 2005, 20:1620-1622.
112. Montastruc J.L., Brefel-Courbon C., Senard J.M., et al. Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic study. Clin Neuropharmacol 2001, 24:181-183.
113. Moskovitz C., Moses H., Klawans H.L. Levodopa-induced psychosis: a kindling phenomenon. Am J Psychiatry 1978, 135:669-675.
114. Nakano K.K., Bass H., Tyler H.R. Levodopa in Parkinson's disease: effect on pulmonary function. Arch Intern Med 1972, 130:346-348.
115. Nausieda P.A., Weiner W.J., Kaplan L.R., et al. Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis. Clin Neuropharmacol 1982, 5:183-194.
116. Nausieda P.A., Glantz R., Weber S., et al. Psychiatric complications of levodopa therapy of Parkinson's disease. Adv Neurol 1984, 40:271-277.
117. Nieves A.V., Lang A.E. Treatment of excessive daytime sleepiness in patients with Parkinson's disease with modafinil. Clin Neuropharmacol 2002, 25:111-114.
118. Nomura T., Inoue Y., Miyake M., et al. Prevalence and clinical characteristics of restless legs syndrome in Japanese patients with Parkinson's disease. Mov Disord 2006, 21:380-384.
119. Olanow C.W., Schapira A.H., Roth T. Waking up to sleep episodes in Parkinson's disease. Mov Disord 2000, 15:212-215.
120. Olson E.J., Boeve B.F., Silber M.H. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain 2000, 123(Part 2):331-339.
121. Ondo W.G., Dat Vuong K., Khan H., et al. Daytime sleepiness and other sleep disorders in Parkinson's disease. Neurology 2001, 57:1392-1396.
122. Ondo W.G., Vuong K.D., Jankovic J. Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol 2002, 59:421-424.
123. Ondo W.G., Fayle R., Atassi F., et al. Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial. J Neurol Neurosurg Psychiatry 2005, 76:1636-1639.
124. Onofrj M., Thomas A., D'Andreamatteo G., et al. Incidence of RBD and hallucination in patients affected by Parkinson's disease: 8-year follow-up. Neurol Sci 2002, 23(Suppl 2):S91-S94.
125. Onofrj M., Luciano A.L., Thomas A., et al. Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism. Neurology 2003, 60:113-115.
126. O'Suilleabhain P.E., Dewey R.B. Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease. Arch Neurol 2002, 59:986-989.
127. Overeem S., van Hilten J.J., Ripley B., et al. Normal hypocretin-1 levels in Parkinson's disease patients with excessive daytime sleepiness. Neurology 2002, 58:498-499.
128. Ozekmekci S., Apaydin H., Kilic E. Clinical features of 35 patients with Parkinson's disease displaying REM behavior disorder. Clin Neurol Neurosurg 2005, 107:306-309.
129. Pacchetti C., Martignoni E., Terzaghi M., et al. Sleep attacks in Parkinson's disease: a clinical and polysomnographic study. Neurol Sci 2003, 24:195-196.
130. Pacchetti C., Manni R., Zangaglia R., et al. Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease. Mov Disord 2005, 20:1439-1448.
131. Pahwa R., Factor S.A., Lyons K.E., et al. Practice Parameter: Treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2006, 66:983-995.
132. Pal S., Bhattacharya K.F., Agapito C., et al. A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy. J Neural Transm 2001, 108:71-77.
133. Pappert E.J., Goetz C.G., Niederman F.G., et al. Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease. Mov Disord 1999, 14:117-121.
134. Paus S., Brecht H.M., Koster J., et al. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease. Mov Disord 2003, 18:659-667.
135. Plazzi G., Corsini R., Provini F., et al. REM sleep behavior disorders in multiple system atrophy. Neurology 1997, 48:1094-1097.
136. Plowman B.K., Boggie D.T., Morreale A.P., et al. Sleep attacks in patients receiving dopamine-receptor agonists. Am J Health Syst Pharm 2005, 62:537-540.
137. Poewe W., Hogl B. Akathisia, restless legs and periodic limb movements in sleep in Parkinson's disease. Neurology 2004, 63:S12-S16.
138. Postuma R.B., Lang A.E., Massicotte-Marquez J., et al. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology 2006, 66:845-851.
139. Priano L., Albani G., Brioschi A., et al. Nocturnal anomalous movement reduction and sleep microstructure analysis in parkinsonian patients during 1-night transdermal apomorphine treatment. Neurol Sci 2003, 24:207-208.
140. Rascol O., Brooks D.J., Korczyn A.D., et al. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group. N Engl J Med 2000, 342:1484-1491.
141. Razmy A., Lang A.E., Shapiro C.M. Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Arch Neurol 2004, 61:97-102.
142. Ringman J.M., Simmons J.H. Treatment of REM sleep behavior disorder with donepezil: a report of three cases. Neurology 2000, 55:870-871.
143. Rissling I., Korner Y., Geller F., et al. Preprohypocretin polymorphisms in Parkinson disease patients reporting " sleep attacks" Sleep 2005, 28:871-875.
144. Rissling I., Frauscher B., Kronenberg F., et al. Daytime sleepiness and the COMT val158met polymorphism in patients with Parkinson disease. Sleep 2006, 29:108-111.
145. Romigi A., Brusa L., Marciani M.G., et al. Sleep episodes and daytime somnolence as result of individual susceptibility to different dopaminergic drugs in a PD patient: a polysomnographic study. J Neurol Sci 2005, 228:7-10.
146. Romigi A., Stanzione P., Marciani M.G., et al. Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson's disease: an open label 24-hour polysomnographic study. J Neural Transm 2006, 113:1909-1913.
147. Rosenthal L., Roehrs T., Sicklesteel J., et al. Periodic movements during sleep, sleep fragmentation, and sleep-wake complaints. Sleep 1984, 7:326-330.
148. Roth T., Rye D.B., Borchert L.D., et al. Assessment of sleepiness and unintended sleep in Parkinson's disease patients taking dopamine agonists. Sleep Med 2003, 4:275-280.
149. Rye D.B. Sleepiness and unintended sleep in Parkinson's disease. Curr Treat Options Neurol 2003, 5:231-239.
150. Rye D.B. Excessive daytime sleepiness and unintended sleep in Parkinson's disease. Curr Neurol Neurosci Rep 2006, 6:169-176.
151. Rye D.B., Bliwise D.L., Dihenia B., et al. FAST TRACK: daytime sleepiness in Parkinson's disease. J Sleep Res 2000, 9:63-69.
152. Sage J.I., Mark M.H. Nighttime levodopa infusions to treat motor fluctuations in advanced Parkinson's disease: preliminary observations. Ann Neurol 1991, 30:616-617.
153. Sanjiv C.C., Schulzer M., Mak E., et al. Daytime somnolence in patients with Parkinson's disease. Parkinsonism Relat Disord 2001, 7:283-286.
154. Santamaria J. How to evaluate excessive daytime sleepiness in Parkinson's disease. Neurology 2004, 63:S21-S23.
155. Santens P. Sleep attacks in Parkinson's disease induced by entacapone, a COMT-inhibitor. Fundam Clin Pharmacol 2003, 17:121-123.
156. Scaglione C., Vignatelli L., Plazzi G., et al. REM sleep behaviour disorder in Parkinson's disease: a questionnaire-based study. Neurol Sci 2005, 25:316-321.
157. Schafer H., Pauleit D., Sudhop T., et al. Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest 2002, 122:829-839.
158. Schapira A.H. Sleep attacks (sleep episodes) with pergolide. Lancet 2000, 355:1332-1333.
159. Schenck C.H., Mahowald M.W. Injurious sleep behavior disorders (parasomnias) affecting patients on intensive care units. Intensive Care Med 1991, 17:219-224.
160. Schenck C.H., Mahowald M.W. REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep 2002, 25:120-138.
161. Schenck C.H., Mahowald M.W. Rapid eye movement sleep parasomnias. Neurol Clin 2005, 23:1107-1126.
162. Schenck C.H., Bundlie S.R., Ettinger M.G., et al. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep 1986, 9:293-308.
163. Schenck C.H., Bundlie S.R., Patterson A.L., et al. Rapid eye movement sleep behavior disorder. A treatable parasomnia affecting older adults. JAMA 1987, 257:1786-1789.
164. Schenck C.H., Hurwitz T.D., Mahowald M.W. REM sleep behavior disorder. Am J Psychiatry 1988, 145:652.
165. Schenck C.H., Milner D.M., Hurwitz T.D., et al. A polysomnographic and clinical report on sleep-related injury in 100 adult patients. Am J Psychiatry 1989, 146:1166-1173.
166. Schenck C.H., Bundlie S.R., Mahowald M.W. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 1996, 46:388-393.
167. Schlesinger I., Ravin P.D. Dopamine agonists induce episodes of irresistible daytime sleepiness. Eur Neurol 2003, 49:30-33.
168. Seneviratne U., Puvanendran K. Excessive daytime sleepiness in obstructive sleep apnea: prevalence, severity, and predictors. Sleep Med 2004, 5:339-343.
169. Silber M.H. Sleep disorders. Neurol Clin 2001, 19:173-186.
170. Sinforiani E., Zangaglia R., Manni R., et al. REM sleep behavior disorder, hallucinations, and cognitive impairment in Parkinson's disease. Mov Disord 2005, 21:462-466.
171. Sinforiani E., Zangaglia R., Manni R., et al. REM sleep behavior disorder, hallucinations, and cognitive impairment in Parkinson's disease. Mov Disord 2006, 21:462-466.
172. Stack E.L., Ashburn A.M. Impaired bed mobility and disordered sleep in Parkinson's disease. Mov Disord 2006, 21:1340-1342.
173. Stern M., Roffwarg H., Duvoisin R. The parkinsonian tremor in sleep. J Nerv Ment Dis 1968, 147:202-210.
174. Stevens S., Cormella C.L., Stepanski E.J. Daytime sleepiness and alertness in patients with Parkinson disease. Sleep 2004, 27:967-972.
175. Stiasny-Kolster K., Doerr Y., Moller J., et al. Combination of " idiopathic" REM sleep behavior disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 2005, 128:126-137.
176. Strickland D., Bertoni J.M. Parkinson's prevalence estimated by a state registry. Mov Disord 2004, 19:318-323.
177. Strieder D.J., Baker W.G., Baringer J.R., et al. Chronic hypoventilation of central origin. A case with encephalitis lethargica and Parkinson's syndrome. Am Rev Respir Dis 1967, 96:501-507.
178. Suchowersky O., Furtado S., Rohs G. Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson's disease. Mov Disord 1995, 10:337-340.
179. Suchowersky O., Reich S., Perlmutter J., et al. Practice Parameter: Diagnosis and prognosis of new onset Parkinson disease (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2006, 66:968-975.
180. Takeuchi N., Uchimura N., Hashizume Y., et al. Melatonin therapy for REM sleep behavior disorder. Psychiatry Clin Neurosci 2001, 55:267-269.
181. Tan E.K. Piribedil-induced sleep attacks in Parkinson's disease. Fundam Clin Pharmacol 2003, 17:117-119.
182. Tan E.K., Lum S.Y., Fook-Chong S.M., et al. Evaluation of somnolence in Parkinson's disease: comparison with age- and sex-matched controls. Neurology 2002, 58:465-468.
183. Tandberg E., Larsen J.P., Karlsen K. A community-based study of sleep disorders in patients with Parkinson's disease. Mov Disord 1998, 13:895-899.
184. Tandberg E., Larsen J.P., Karlsen K. Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study. Mov Disord 1999, 14:922-927.
185. Thorpy M.J., Adler C.H. Parkinson's disease and sleep. Neurol Clin 2005, 23:1187-1208.
186. Ulivelli M., Rossi S., Lombardi C., et al. Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD. Neurology 2002, 58:462-465.
187. Van den Kerchove M., Jacquy J., Gonce M., et al. Sustained-release levodopa in parkinsonian patients with nocturnal disabilities. Acta Neurol Belg 1993, 93:32-39.
188. van Hilten B., Hoff J.I., Middelkoop H.A., et al. Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoring. Arch Neurol 1994, 51:922-928.
189. van Hilten J.J., Kabel J.F., Middelkoop H.A., et al. Assessment of response fluctuations in Parkinson's disease by ambulatory wrist activity monitoring. Acta Neurol Scand 1993, 87:171-177.
190. Van Someren E.J. Actigraphic monitoring of movement and rest-activity rhythms in aging, Alzheimer's disease, and Parkinson's disease. IEEE Trans Rehabil Eng 1997, 5:394-398.
191. Vetrugno R., Provini F., Cortelli P., et al. Sleep disorders in multiple system atrophy: a correlative video-polysomnographic study. Sleep Med 2004, 5:21-30.
192. Wetter T.C., Collado-Seidel V., Pollmacher T., et al. Sleep and periodic leg movement patterns in drug-free patients with Parkinson's disease and multiple system atrophy. Sleep 2000, 23:361-367.
193. Winkelman J.W., James L. Serotonergic antidepressants are associated with REM sleep without atonia. Sleep 2004, 27:317-321.
194. Yoshida T., Kono I., Yoshikawa K., et al. Improvement of sleep hypopnea by antiparkinsonian drugs in a patient with Parkinson's disease: a polysomnographic study. Intern Med 2003, 42:1135-1138.
195. Young A., Home M., Churchward T., et al. Comparison of sleep disturbance in mild versus severe Parkinson's disease. Sleep 2002, 25:573-577.